Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Cocrystal Pharma, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 20 | 16 | −4 |
| Shares | 666.9K | 704.2K | +37.3K (+5.6%) |
| Value | $1.59M | $1.32M | −$277.4K (−17.4%) |
New holders (0)
Institutions that held Cocrystal Pharma, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (4)
Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Parallel Advisors, LLC | 15,228 | $36.4K |
| Clean Yield Group | 418 | $999 |
| UBS Group AG | 276 | $660 |
| Advisor Group Holdings, Inc. | 2 | $5 |